scholarly journals Additional cost of end-stage kidney disease in diabetic patients according to renal replacement therapy modality: a systematic review

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Isabella Vanorio-Vega ◽  
Panayotis Constantinou ◽  
Philippe Tuppin ◽  
Cécile Couchoud
Keyword(s):  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
Cost Of Care ◽  
Treatment Modalities ◽  
Diabetic Patients ◽  
End Stage Kidney Disease ◽  
Costly Treatment ◽  
End Stage ◽  
The Cost

AbstractThe prevalence of end-stage kidney disease (ESKD) is growing worldwide; the survival of these patients requires renal replacement therapy (RRT, a complex and costly treatment). Over 20% of the patients that start RTT had diabetes. Limited evidence on the effect of comorbidities on the cost of RRT exists. This review summarizes the available evidence on the effect of diabetes mellitus (DM) on the cost of RRT. Electronic databases were searched using key words that combined RRT with DM and cost. References were identified with title, abstract, and full-text screening. The studies included were published in English and presented data on the cost of RRT in ESKD patients with comparison between DM status. Seventeen studies were included in this review. The crude and adjusted cost of care estimates for patients on dialysis was generally higher for DM patients. The cost of care of ESKD patients differed according to various treatment modalities and these differences, mainly driven by inpatient costs. Overall, we found an increased cost of RRT care in patients with DM regardless of the type of treatment. Future analysis of the effects of multiple comorbidities should be considered to better understand the effect of DM on the cost of RRT.

scholarly journals Advocacy for renal replacement therapy: the role of renal registries

2020 ◽  
Vol 13 (5) ◽  
pp. 742-744
Author(s):  
Cecile Couchoud ◽  
Mohamed Benghanem Gharbi
Keyword(s):  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
South African ◽  
Limited Resource ◽  
Service Planning ◽  
End Stage Kidney Disease ◽  
End Stage ◽  
Resource Environment

Abstract The paper by Jardine et al. reporting results from the South African Renal Registry describes a 2-fold success. First, even in a limited-resource environment, survival of patients on renal replacement therapy (RRT) is favourable. Secondly, this information is available because a few years ago, South African nephrologists started a renal registry. These successes cannot conceal, however, that numerous patients are not offered RRT. Robust health information systems make it possible to define chronic kidney disease and end-stage kidney disease (ESKD) burdens, guide resource allocation, inform service planning and enable policy. Registries can highlight inequitable RRT access and help support advocacy in favour of additional resources for ESKD care.

scholarly journals Factors promoting shared decision-making in renal replacement therapy for patients with end-stage kidney disease: systematic review and qualitative meta-synthesis

2021 ◽  
Author(s):  
Yu Shi ◽  
Wang Li ◽  
Fangjian Duan ◽  
Shi Pu ◽  
Hongmei Peng ◽  
...  
Keyword(s):  
Systematic Review ◽  
Decision Making ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
Shared Decision Making ◽  
Shared Decision ◽  
End Stage Kidney Disease ◽  
Related Factors ◽  
End Stage

Abstract Purpose Shared decision-making (SDM) about the type of renal replacement therapy to use is a matter of great importance involving patients, their families, and health treatment teams. This review aims to synthesize the volume of qualitative work explaining the factors influencing SDM regarding renal replacement therapy. Methods A systematic review and qualitative meta-synthesis approach recommended by JBI was used, six databases were searched. Studies were qualitative or mixed research published since 2000, with a primary focus on patient experiences, perceptions and practices regarding which method to choose for renal replacement therapy in End-Stage Kidney Disease (ESKD) patients. All themes were analyzed and compared to the established connectedness. Results A total of 1313 patients were enrolled in 32 studies focusing on factors associated with SDM regarding renal replacement therapy were included. All quality evaluations of the literature were medium to high. Four common themes were identified in our synthesis: (1) patient personal reasons, (2) family-related factors, (3) health care professional-related factors, and (4) social factors influence. Conclusion The model proposes pathways that could be explored further in future qualitative and quantitative studies and suggests that patients’ beliefs, emotions, and awareness should be targeted alongside patients’ decision-making practices to increase the efficacy of interventions. The majority of studies included in this review focus on older patients, and all report patients’ perspectives. Further research is required to understand the family member perspectives on SMD of renal replacement therapy.

Epidemiology of End-Stage Kidney Disease on Renal Replacement Therapy: 35 Years Analysis Study Nephrologists

2021 ◽  
Vol 32 (1) ◽  
pp. 183
Author(s):  
RuqiyaK Al-Za’abi ◽  
ElizabethP Tolmie ◽  
AnnMarie Rice ◽  
Nabil Mohsin ◽  
AhmedSaid Al-Busadi
Keyword(s):  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
End Stage Kidney Disease ◽  
Analysis Study ◽  
End Stage

scholarly journals Non-medical barriers reported by nephrologists when providing renal replacement therapy or comprehensive conservative management to end-stage kidney disease patients: a systematic review

2020 ◽  
Author(s):  
Rianne W de Jong ◽  
Vianda S Stel ◽  
James G Heaf ◽  
Mark Murphy ◽  
Ziad A Massy ◽  
...  
Keyword(s):  
Systematic Review ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Focus Groups ◽  
Replacement Therapy ◽  
Conservative Management ◽  
End Stage Kidney Disease ◽  
Cross Sectional ◽  
Financial Barriers ◽  
End Stage

Abstract Background Large international differences exist in access to renal replacement therapy (RRT) modalities and comprehensive conservative management (CCM) for patients with end-stage kidney disease (ESKD), suggesting that some patients are not receiving the most appropriate treatment. Previous studies mainly focused on barriers reported by patients or medical barriers (e.g. comorbidities) reported by nephrologists. An overview of the non-medical barriers reported by nephrologists when providing the most appropriate form of RRT (other than conventional in-centre haemodialysis) or CCM is lacking. Methods We searched in EMBASE and PubMed for original articles with a cross-sectional design (surveys, interviews or focus groups) published between January 2010 and September 2018. We included studies in which nephrologists reported barriers when providing RRT or CCM to adult patients with ESKD. We used the barriers and facilitators survey by Peters et al. [Ruimte Voor Verandering? Knelpunten en Mogelijkheden Voor Verbeteringen in de Patiëntenzorg. Nijmegen: Afdeling Kwaliteit van zorg (WOK), 2003] as preliminary framework to create our own model and performed meta-ethnographic analysis of non-medical barriers in text, tables and figures. Results Of the 5973 articles screened, 16 articles were included using surveys (n = 10), interviews (n = 5) and focus groups (n = 1). We categorized the barriers into three levels: patient level (e.g. attitude, role perception, motivation, knowledge and socio-cultural background), level of the healthcare professional (e.g. fears and concerns, working style, communication skills) and level of the healthcare system (e.g. financial barriers, supportive staff and practice organization). Conclusions Our systematic review has identified a number of modifiable, non-medical barriers that could be targeted by, for example, education and optimizing financing structure to improve access to RRT modalities and CCM.

Early effects of renal replacement therapy on cardiovascular comorbidity in children with end-stage kidney disease

2017 ◽  
pp. 1 ◽  
Author(s):  
Bernhard M.W. Schmidt ◽  
Rizky I. Sugianto ◽  
Daniela Thurn ◽  
Karolis Azukaitis ◽  
Aysun K. Bayazit ◽  
...  
Keyword(s):  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
End Stage Kidney Disease ◽  
Cardiovascular Comorbidity ◽  
Early Effects ◽  
End Stage

scholarly journals Renal replacement therapy for refugees with end-stage kidney disease: an international survey of the nephrological community

2016 ◽  
Vol 6 (2) ◽  
pp. 35-41 ◽  
Author(s):  
Wim Van Biesen ◽  
Raymond Vanholder ◽  
Bert Vanderhaegen ◽  
Norbert Lameire ◽  
Christoph Wanner ◽  
...  
Keyword(s):  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
International Survey ◽  
End Stage Kidney Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document